A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)
Public ClinicalTrials.gov record NCT02855411. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12 Week, Phase 2, Randomized, Double-blind, Placebo Controlled, Parallel Group Study To Evaluate The Safety And Efficacy Of Pf-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether PF-04958242 is safe and effective in the treatment of cognitive dysfunction in schizophrenia subjects
Study identification
- NCT ID
- NCT02855411
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 35 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 28, 2016
- Primary completion
- Sep 25, 2016
- Completion
- Sep 25, 2016
- Last update posted
- Jan 8, 2020
2016
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Collaborative Neuroscience Network, LLC (Investigator Site File Location) | Garden Grove | California | 92845 | — |
| Collaborative Neuroscience Network, LLC | Garden Grove | California | 92845 | — |
| Excell Research, Inc | Oceanside | California | 92056 | — |
| NRC Research Institute | Orange | California | 92868 | — |
| California Neuropsychopharmacology Clinical Research Institute, LLC (CNRI-San Diego, LLC) | San Diego | California | 92102 | — |
| Collaborative Neuroscience Network, LLC | Torrance | California | 90502 | — |
| Atlanta Center For Medical Research | Atlanta | Georgia | 30331 | — |
| Alexian Brothers Centers for Psychiatric Research | Hoffman Estates | Illinois | 60169 | — |
| Chinmay K. Patel, D.O. | Hoffman Estates | Illinois | 60169 | — |
| Lake Charles Clinical Trials | Lake Charles | Louisiana | 70629 | — |
| CBH Health, LLC | Gaithersburg | Maryland | 20877 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| CRI Worldwide, LLC | Marlton | New Jersey | 08053 | — |
| Research Strategies of Memphis, LLC | Memphis | Tennessee | 38119 | — |
| Pillar Clinical Research, LLC | Dallas | Texas | 75243 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02855411, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2020 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02855411 live on ClinicalTrials.gov.